|Day Low/High||97.19 / 100.49|
|52 Wk Low/High||56.20 / 103.03|
All these names, I believe, have potential positive catalysts, but they all can drift lower in a poor market.
It is the nature of trading to be caught by surprise and the most important thing is to just take it in stride the best you can.
Now's the time to take a step back and prepare mentally for what happens next.
There a several names that I expect to see strong earnings results from.
While I'm reducing some of my bigger positions into strength, I'm definitely not bearish.
This isn't a market with a lot of very extended stocks so the chances of catching some names at support are good.
Stick to themes like biotechnology, SPACs, EV batteries, and others.
Don't be in a rush. The key to accumulating stocks in this environment is to move incrementally.
Here are several names I'm looking to build on further weakness.
There are some concerns in the price action but dip buyers keep stepping up very quickly.
Good individual traders will produce returns far in excess of anything that traditional Wall Street will earn.
These names are showing bullish and bearish technical patterns over the past week.
The Dublin firm on Nov. 6 unveiled third-quarter numbers that topped analysts' estimates and raised its full-year net sales outlook and the lower end of its 2017 adjusted Ebitda guidance.
Volatility sank to its lowest level since 1993 to begin the new week as indexes held close to their flatlines.
Horizon's nueromuscular disorder treatment trials failed.
No matter who wins the election, there are ways to make money.
Relief flooded Wall Street after a number of Fed speakers took a dovish turn following increasingly hawkish rhetoric.
Social media chatter also included takes by Michael Bloomberg and Warren Buffett on small-business success.
Don't be surprised if HZNP trends lower to next chart support around $10.
But for the brave, they could offer a solid bottom-fishing opportunity.
Automakers are reporting sales results today, and Ford is Jim Cramer’s top pick in the auto sector.
Valuations of some small-cap concerns, such as Relypsa, are ridiculously cheap.